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CBF-1 promotes transcriptional silencing during
the establishment of HIV-1 latency
Mudit Tyagi and Jonathan Karn*
Department of Molecular Biology and Microbiology, School of Medicine,
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The establishment of HIV proviral latency requires the
creation of repressive chromatin structures that impair the
initiation of transcription and restrict RNAP II elongation.
We have found that C-promoter binding factor-1 (CBF-1), a
CSL (CBF-1, Su(H) and Lag-1)-type transcription factor and
key effector of the Notch signaling pathway, is a remark-
ably potent and speciﬁc inhibitor of the HIV-1 LTR pro-
moter. Knockdown of endogenous CBF-1 using speciﬁc
small hairpin RNAs expressed on lentiviral vectors results
in the partial reactivation of latent HIV proviruses, recruit-
ment of RNAP II, loss of histone deacetylases and the
concomitant acetylation of histones. An important prop-
erty of any repressor utilized to establish HIV latency is
that it must become displaced or deactivated upon T-cell
activation. Consistent with this hypothesis, CBF-1 mRNA
and protein levels are highest in quiescent or unstimu-
lated Tcells but decline rapidly in response to proliferative
stimulation such as activation of the T-cell receptor or
treatment with TNF-a. We conclude that CBF-1 is a pre-
viously overlooked factor that induces transcriptional
silencing during the establishment of HIV latency.
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Introduction
The introduction of highly active antiretroviral therapy in the
mid-1990s led to a dramatic increase in patient longevity due
to the ability of antiretroviral drugs to suppress HIV replica-
tion to below threshold detection levels (o50 copies HIV
RNA/ml) (Ho et al, 1995; Wei et al, 1995). Unfortunately,
despite the intensive therapy, active viral replication imme-
diately resumes after the interruption of antiviral treatment
due to reactivation of latent viral reservoirs (Chun et al,
2000). The ability of HIV to enter and exit from latency is
therefore one of the major features of the virus life cycle that
prevents the clearance of the virus from infected individuals
and limits the effectiveness of current antiviral therapy.
The prevailing consensus is that no single molecular
mechanism is responsible for latency. Instead, an absence
of the cellular initiation factors NF-kB and NFAT (Nabel and
Baltimore, 1987; Kinoshita et al, 1997), a restriction in the
levels of the HIV transactivator protein Tat (Lin et al, 2003)
and a reduction in the level of the Tat-activated elongation
factor P-TEFb (Ghose et al, 2001) are all believed to con-
tribute to the shutdown of viral transcription.
The establishment of speciﬁc restrictive chromatin struc-
tures at the HIV LTR is believed to be the primary event
leading to the restriction in Tat levels during the establish-
ment of latency. Important work from the Verdin laboratory
has shown that the chromatin structure of the HIV LTR
contains two well-ordered nucleosomes called Nuc-0 and
Nuc-1 (Verdin et al, 1993; Emiliani et al, 1996). Nuc-0 is
positioned immediately upstream of the enhancer ( 415 to
 255), while Nuc-1 is very close to the viral RNA start site
(þ10 to þ155). Reactivation of HIV transcription requires
histone acetylation and remodeling of the critical Nuc-1
by SWI/SNF (Lusic et al, 2003; Henderson et al, 2004;
Mahmoudi et al, 2006; Treand et al, 2006).
Recent studies have shown that the presence of histone
deacetylases (HDACs) at the HIV LTR is strongly correlated
with transcriptional repression leading to latency. Initial
interest in this mechanism was stimulated by the work of
Margolis and his colleagues who demonstrated that the
transcription factor YY1 can act as a repressor of HIV
transcription by recruiting HDAC-1 to the provirus (Coull
et al, 2000; He and Margolis, 2002). Subsequently, it was
found that drugs that inhibit HDAC activity such as tricho-
statin A and valproic acid (Ylisastigui et al, 2004; Lehrman
et al, 2005) are effective inducers of HIV transcription in
latently infected cells. Recently, Williams et al (2006) have
reported that removal of p50 by shRNA results in a loss of
HDACs from the HIV LTR and reactivation of transcription
from latent proviruses.
Entry of HIV into latency also requires the establishment of
heterochromatic structures on the HIV provirus. Two recent
reports demonstrate that the histone methyltransferase
Suv39H1, histone H3 methylated on K9 and K27, and the
repressive HP1 proteins all accumulate on transcriptionally
inactive proviruses (du Che ´ne ´ et al, 2007; Marban et al,
2007). Furthermore, HIV-1 reactivation could be achieved
after removal of HP1g by RNA interference (du Che ´ne ´ et al,
2007).
Although multiple factors are required to establish viral
latency, the reactivation of latent proviruses can be achieved
by the simple induction of NF-kB (West et al, 2001; Scripture-
Adams et al, 2002; Brooks et al, 2003). NF-kB induces multi-
ple changes at the promoter of latent proviruses, including
the recruitment of TFIIH and RNAP II (Kim et al, 2006). NF-
kB also induces changes in the local chromatin structure at
the HIV LTR by recruiting histone acetyltransferases, such as
CBP and p300 to the HIV-1 LTR (Gerritsen et al, 1997; Krogan
et al, 2002) and chromatin remodeling factors (Lusic et al,
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The initial signals used to create speciﬁc repressive chro-
matin structures at the HIV promoter are largely unknown.
We have been investigating whether gene-speciﬁc repressors
can target the HIV LTR. Our initial studies have focused
on C-promoter binding factor-1 (CBF-1), the mammalian
representative of the CSL family. CSL family proteins
(CBF-1 and Su(H) in Drosophila melanogaster and Lag-1 in
Caenorhabditis elegans) are essential primary effectors of
the Notch signaling pathway and are known to be able to
recruit HDAC corepressor complexes to many different cellu-
lar and viral promoters carrying appropriate DNA-binding
sites (Lai, 2002).
Here, we demonstrate that CBF-1 is a speciﬁc and potent
inhibitor of the HIV-1 promoter, both in the presence and
absence of Tat. Using chromatin immunoprecipitation (ChIP)
assays, we demonstrated that CBF-1 strongly reduces the
amount of RNAP II at the promoter, recruits HDACs to the
LTR and nearly totally abolishes acetylation of core histones
at Nuc-1. Knockdown of endogenous CBF-1 by shRNA results
in the partial reactivation of latent HIV proviruses, recruit-
ment of RNAP II to the proviral promoter, loss of histone
deacetylases and the concomitant acetylation of histones.
Thus, CBF-1 is a previously overlooked T-cell-speciﬁc regu-
latory factor that can silence HIV transcription and promote
HIV entry into latency.
Results
CBF-1 is a potent repressor of HIV-1 transcription
Although HDACs can act as potent repressors of the HIV LTR,
it is unknown how these factors are recruited to the provirus.
Surprisingly, our preliminary experiments showed that over-
expression of HDACs in trans did not result in HIV transcrip-
tional silencing. This prompted us to look for mediator
proteins that could be used to recruit HDACs. We focused
our attention on CBF-1 because this protein is known to be
expressed in T cells and our sequence analysis of the HIV
identiﬁed several putative CBF-1-binding sites.
As shown in Figure 1, HeLa and Jurkat Tcells infected with
lentiviral vectors carrying luciferase reporter genes were used
to measure the impact of CBF-1 expression in trans on the
promoter activity of the HIV-1 LTR. The cells were infected
with either pHR0P-Luc, a lentiviral vector carrying the lucifer-
ase reporter gene under the control of the HIV LTR, or as a
control, with pHR0P-SIN18-Luc, a self-inactivating (SIN) len-
tiviral vector carrying a luciferase reporter transcribed by an
internal human cytomegalovirus (CMV) immediate-early pro-
moter. The cells were then transfected with up to 3mgo f
pcDNA3-CBF-1, a plasmid expressing CBF-1 under the con-
trol of the CMV promoter together with 200ng of pcDNA3-
Tat, a plasmid expressing Tat.
The repression of HIV transcription by CBF-1 is remarkably
potent. In both cell lines, there was a clear dose-dependent
inhibition of LTR promoter activation by CBF-1 that could be
ﬁtted to an exponential decay function. In the HeLa cells,
half-maximal inhibition was reached at approximately 800ng
(Figure 1A), whereas in Jurkat T cells (Figure 1B) half-
maximal inhibition was observed at 3mg of CBF-1 plasmid
DNA because of the lower transfection efﬁciency. This
was conﬁrmed by direct measurements of CBF-1 protein
expression (Supplementary Figure S1). In contrast, luciferase
expression under CMV promoter was only weakly inhibited
by CBF-1. At 3mg of CBF-1 DNA, CMV transcription was
inhibited by less than 20% in HeLa cells and less than 10% in
the Jurkat T cells. CBF-1 is also able to repress basal HIV-1
transcription in the absence of Tat, indicating that it functions
at the level of transcriptional initiation (Supplementary
Figure S2).
In contrast to CBF-1, NF-kB p50, which was previously
reported to repress HIV transcription in latently infected cells
(Williams et al, 2006), was a powerful inducer of HIV
transcription in HeLa cells, leading to a 12-fold increase in
luciferase activity. As expected, the control CMV promoter,
which lacks NF-kB-binding sites, was unaffected by p50. In
Jurkat Tcells, p50 did not signiﬁcantly induce HIV transcrip-
tion. The failure of p50 to induce HIV transcription in Jurkat
T cells could either be due to the occupation of the HIV NF-
kB-binding sites by other factors in this cell line or the
absence of appropriate cofactors.
As shown in Figure 1E and F, overexpression of HDACs did
not lead to the repression of HIV LTR, indicating that speciﬁc
mediator proteins, such as CBF-1, are required to allow HDAC
interactions with the provirus.
HIV-1 LTR contains two distinct high-afﬁnity
CBF-1-binding sites
Trans-repression by CBF-1 requires its binding to speciﬁc
high-afﬁnity DNA-binding sequences which are related to
the TGGGAA consensus sequence. To conﬁrm that the LTR
carries binding sites for CBF-1, we performed gel-retardation
assays using puriﬁed GST-CBF-1 protein kindly provided by
Dr Katherine Jones (Salk). As shown in Figure 2, CBF-1 is
able to bind with high afﬁnity to sequences overlapping the
NF-kB elements of LTR-enhancer region (AGGGAC and
GGGGAC). Mutation of the GGG sequence to CTC (West
et al, 2001), which blocks NF-kB binding, also abolished
CBF-1 binding. CBF-1 is also able to bind to a putative CBF-
1-binding site (TGGGAA) at position þ148 to þ153.
Introduction of point mutations in the putative CBF-1-binding
site (from TGGGAA to ACTATC) abolished CBF-1 binding. As
negative control, we chose a fragment of pcDNA3 vector,
which does not contain any putative CBF-1-binding site. As
expected, this fragment was unable to bind GST-CBF-1 pro-
tein. Thus, our results clearly demonstrate that there are two
speciﬁc binding sites for CBF-1 located in the HIV-1 LTR.
Establishment of latently infected Jurkat T-cell lines
To develop a biochemically tractable experimental system for
the study of the impact of CBF-1 on HIV transcription, we
have used lentiviral vectors to generate T-cell lines carrying
integrated proviruses expressing ﬂuorescent protein reporter
genes. An important feature of the viruses that we have
constructed (Figure 3A) is that, like HIV itself, they are
activated in cis by the regulatory proteins Tat and Rev (Kim
et al, 2006). In these vectors, either the d2EGFP or mCherry
ﬂuorescent proteins were inserted in place of the Nef gene
and were used as reporters to monitor HIV transcription.
As described previously by Kim et al (2006), immediately
after infection of the cells with the lentiviral vectors there is a
high level of gene expression, which falls progressively over
the next few weeks until the majority of the initially infected
cells become latently infected and no longer express the
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into latency was initially observed by Li et al (1996) and later
conﬁrmed by Weinberger and colleagues (Weinberger et al,
2005; Weinberger and Shenk, 2006). The experiments in this
paper were performed using viruses carrying either the wild-
type Tat gene or viruses carrying the H13L mutation, a
partially attenuated Tat variant originally identiﬁed in latently
infected cells (Emiliani et al, 1998; Reza et al, 2003) that
produces a high frequency of latently infected cells. Similar
latently infected cell lines such as the J-Lat 6.3 cells (Jordan
et al, 2003; Williams et al, 2006, 2007) and J89GFP and
THP89GFP cells (Kutsch et al, 2002, 2003) have been devel-
oped using lentiviruses carrying ﬂuorescent protein markers.
Two examples of latently infected clones are shown in
Figure 3B and C. The Jurkat E4 clone carries a wild-type Tat
and the d2EGFP reporter, whereas the Jurkat-mCherry-clone
2 was isolated from a shutdown population of cells infected
with the H13L virus. Both the clonal cell lines show an
extremely high degree of shutdown and reactivation. More
than 95% of the latently infected E4 or clone 2 cells show no
detectable reporter gene expression. An advantage of these
clones compared to the J-Lat 6.3 model for HIV latency
(Jordan et al, 2003), which has been extensively used by
Warner Greene and colleagues (Williams et al, 2006, 2007), is
that HIV transcription can be induced in over 90% of the cells
following treatment of the cells with TNF-a to activate NF-kB,
Figure 1 Inhibition of HIV transcription by CBF-1. HeLa (A) and Jurkat Tcells (B) carrying latent proviruses expressing the luciferase reporter
gene (pHR0-P-Luc; HIV) were co-transfected with between 0 and 3000ng of a plasmid expressing CBF-1 protein (pcDNA3-CBF-1) along with
200ng of a Tat-expressing plasmid (pcDNA3-Tat). Control cells were infected with pHR0P-SIN-18-Luc (CMV). In parallel experiments, latently
infected HeLa (C) and Jurkat cells (D) were co-transfected with between 0 and 3000ng of a plasmid expressing NF-kB p50 (pRSV-p50) (West
et al, 2001) and 200ng of pcDNA3-Tat. Latently infected HeLa (E) and Jurkat cells (F) were also co-transfected with between 0 and 3000ng of a
plasmid expressing HDAC-1 and 200ng of pcDNA3-Tat. After 48h, cell extracts were checked for luciferase activity. Each data set was
normalized, with 100% equal to the activity of cells transfected by pcDNA3-Tat alone. As an additional control, basal luciferase levels in the
absence of Tat are shown in (A, B).
CBF-1 represses HIV transcription
M Tyagi and J Karn
&2007 European Molecular Biology Organization The EMBO Journal VOL 26 | NO 24 | 2007 4987whereas only 30% of the J-Lat 6.3 cells can be reactivated
under these conditions. This demonstrates that none of
the cells in the E4 and clone 2 lines have lost the latent
proviruses.
CBF-1 recruits HDACs and corepressor complexes to the
LTR of latent proviruses
CBF-1 typically exerts its transcriptional repressive effect by
recruiting HDAC-containing corepressor complexes. To con-
ﬁrm that both CBF-1 and corepressor complex(es) were
present at the HIV-1 LTR, ChIP assays were performed using
the Jurkat E4 clone (Figure 3D). The immunoprecipitated
DNA was measured using primers directed to the promoter
region of LTR ( 116 to þ4 with respect to transcription start
site). Since the chromatin fragments used in this experiment
were randomly sheared to approximately 400nt length, the
majority of the signal detected in this experiment can be
attributed to proteins bound within the  200 to þ200 region
of the HIV LTR. As shown in Figure 3D, the latently infected
clone E4 cells have low, but detectable, levels of RNAP II at
the promoter, whereas CBF-1 and its corepressor subunits
CIR and mSIN3A are all present at high levels. As expected
Figure 2 Complex formation between HIV LTR and CBF-1 protein.
Gel-retardation assays were performed using 0–300ng puriﬁed GST-
CBF-1 protein and fragments of the HIV LTR. Left: CBF-1 fragment
(þ76 to þ255); right: NF-kB fragment ( 160 to  22). LTR
fragments with mutated CBF-1-binding sites were used as speciﬁcity
controls. A fragment of the pcDNA3 vector was used as negative
control for CBF-1 binding (far left: control). GSTalone was used as
control for protein.
Figure 3 CBF-1 blocks HIV transcription in latently infected cells by recruiting HDACs. (A) Lentiviral vectors. (B) Induction of HIV
transcription by TNF-a clone E4 cells. The cells were latently infected with the HIV d2EGFP virus (wild-type Tat) and induced for 18h with
10ng/ml TNF-a.( C) Induction of HIV transcription by TNF-a in Jurkat clone 2 cells. The cells were latently infected with the HIV mCherry
virus (H13L Tat). (D) The distribution of transcription factors on the HIV LTR in clone E4 cells was analyzed by quantitative chromatin
immunoprecipitation (ChIP) assays using the indicated antibodies before and after TNF-a stimulation. (E) Control ChIP experiment using the
GAPDH gene. Red bars: unstimulated cells; purple bars: þ20ng/ml TNF-a for 24h.
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whereas acetylated histone H3 and H4 are present at only
very low levels. Similarly, the transcriptional activator p300,
and the NF-kB subunits p65 and p50 are present at only
baseline levels. As demonstrated below (Figure 6), the re-
cruitment of HDACs to the HIV LTR requires CBF-1.
To provide a control for the speciﬁcity of the ChIP assay,
we also examined the GAPDH gene (Figure 3E) using the
same immunoprecipitated samples that were used to study
the HIV promoter (Figure 3D). RNAP II and acetylated
histones were present on the GAPDH gene at relatively
constant levels before and after TNF-a treatment. As
expected, CBF-1 and its cofactors as well as p300 and the
NF-kB subunits p65 and p50 were all absent.
We have also observed that the latent provirus in clone E4
cells carries heterochromatic markers, including K9- and K27-
methylated histone H3, and the HP1a and HIP1g proteins, in
agreement with the results of du Che ´ne ´ et al (2007) and
Marban et al (2007) (data not shown).
If the HIV LTR is transcriptionally repressed due to CBF-1,
then it is likely that it is displaced from the promoter
following NF-kB induction. To test this hypothesis, ChIP
assays were performed on the Jurkat E4 cells treated with
TNF-a (Figure 3D). Induction of the latently infected cells by
treatment with TNF-a increased RNAP II at the promoter over
14-fold. In contrast, CBF-1, CIR, mSIN3A and HDAC-1 levels
fell to baseline levels as RNAP II levels rose. As expected,
TNF-a induction resulted in p65 and p300 recruitment to the
promoter. Similar results were obtained when Jurkat clone 2
(Figure 6) or Jurkat cells latently infected by pHR0-Luc
(Supplementary Figure S3) were induced by TNF-a.
Thus, in three different clonal cell lines carrying latent
proviruses, CBF-1 and its cofactors were present at the HIV
LTR prior to induction of transcription by NF-kB. It is
important to note that since CBF-1 exerts its effects by direct
interaction with the HIV LTR, uniform results were obtained
using proviruses that carried either the wild-type Tat (clone
E4), the attenuated H13L Tat (clone 2) or no Tat (pHR0-Luc).
CBF-1 inhibits HIV transcription in newly infected cells
To measure the impact of CBF-1 during the early stages of
viral infection, we prepared Jurkat cell lines in which CBF-1
was knocked down by shRNA expressed by lentiviral vectors
(Figure 4A). As shown in Figure 4B, endogenous CBF-1 was
reduced by over 75% in the Jurkat-CBF-1-shRNA cells com-
pared to the control cells not expressing the shRNA.
To evaluate the effects of CBF-1 knockdown on HIV
transcription, we compared a matched pair of cell lines
carrying lentiviral vectors that expressed either shRNA to
CBF-1 or scrambled shRNA control (Figure 4C). The cells
were superinfected with the HIV mCherry virus and analyzed
by ﬂow cytometry between 24 and 72h post-infection. At
each time point, the CBF-1-ablated cells showed a 3- to 4-fold
higher proportion of mCherry expressing cells than the con-
trol cells. Comparable results are shown in Supplementary
Figures S4–S6 where HIV viruses carrying either the wild-
Figure 4 CBF-1 limits HIV gene expression in newly infected Jurkat T cells. (A) Structure of lentiviral vectors. (B) Western blot showing
nuclear levels of CBF-1 in control cells and cells expressing shRNA to CBF-1. Top panel: CBF-1 antibody; bottom panel: Spt-5 antibody loading
control. (C) Flow cytometric analysis of Jurkat T-cell lines with lentiviral vectors. Red line: CBF-1 shRNA; purple line: scrambled shRNA
control; black line: uninfected cells. After 24h, the cells were superinfected with HIV mCherry at an m.o.i. of 1.5 and monitored for mCherry
expression over the next 72h.
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two-dimensional plot.
We conclude that endogenous levels of CBF-1 are sufﬁ-
ciently high to be able to restrict HIV transcription in newly
infected T cells.
Knockdown of CBF-1 in resting cells partially activates
latent proviruses and induces an ‘open’ chromatin
structure at the HIV LTR
If CBF-1 plays a signiﬁcant role in HIV silencing, then it
should be possible to at least partially reactivate the latent
proviruses by knockdown of the endogenous CBF-1 using
shRNA. To test this hypothesis, the latently infected Jurkat-
clone 2 cell line (mCherry) was superinfected with lentiviral
vectors carrying either shRNA against CBF-1 or an empty
vector control (Figure 5). The shRNA vectors carried the
EGFP reporter under the control of the CMV promoter to
provide a marker for the cells expressing shRNA (Figure 4A).
Knockdown of CBF-1 due to expression of the CBF-1
shRNA resulted in partial activation of the latent proviruses.
At 48h after infection, 33% of the cells showed increased HIV
mCherry (RFP) expression (Figure 5A). In comparison, only
9% of control cells infected with the empty lentiviral vector
(minus shRNA) showed enhanced mCherry expression. The
partial activation of these cells is probably due to the scarcity
of NF-kB in the unactivated cells. To demonstrate the require-
ment for NF-kB, and that none of these cells had lost the
integrated latent HIV-1 proviruses, Jurkat clone 2 cells and its
Figure 5 Knockdown of CBF-1 by shRNA leads to partial induction of latent HIV. (A) Two-color ﬂow cytometric analysis. Jurkat Tcells latently
infected by HIV mCherry (clone 2 cells) were superinfected by shRNA vectors. Left: clone 2 cells; middle: empty vector control; right: CBF-1
shRNA; top panels: unstimulated cells; bottom panels: cells treated with 20ng/ml TNF-a for 16h. (B) Activation of HIV expression following
superinfection by vectors expressing scrambled shRNA and CBF-1 shRNA. Black line: uninduced clone 2 cells; blue line: scrambled shRNA;
purple line: CBF-1 shRNA; red line: induced by TNF-a.( C) Induction of luciferase expression in Jurkat pHR0P-Luc (HIV) and Jurkat pHR0P-SIN-
18-Luc (CMV) by CBF-1 shRNA. The cells were infected with lentiviral vectors carrying shRNA to p50, p65, CBF-1, IKK-b or a scrambled shRNA
control.
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three cell populations, more than 97% of the induced cells
expressed mCherry at high levels. Comparable results are
shown in Figure 5B, which compares the extent of activation
of HIV gene expression in clone 2 cells following infection by
vectors expressing a scrambled shRNA control and CBF-1
shRNA. Similarly, CBF-1 shRNA was able to increase lucifer-
ase expression in Jurkat cells latently infected with the
pHR0P-Luc vector to 183% of the control values, whereas
shRNA to p50 or p65 reduced proviral expression to 37 and
32%, respectively of the control values (Figure 5C).
We also evaluated the impact of CBF-1 knockdown on HIV
gene expression by ChIP assays using primers for the pro-
moter (Figure 6). Since the clone 2 cells are latently infected
there was only a low level of RNAP II associated with the
promoter either in the absence of activation signals or when
clone 2 cells were infected with an empty shRNA lentiviral
vector. Infection by the lentiviral vectors carrying CBF-1
shRNA resulted in a twofold increase in RNAP II at the
promoter. Control ChIP experiments show that the knock-
down of CBF-1 reduced it to undetectable levels at the HIV
promoter. There was a parallel decline in CIR and HDAC-1
levels. In contrast, acetylated histone H3 levels increased
when CBF-1 was knocked down. Thus, removal of CBF-1
leads to a loss of HDAC-containing corepressor complexes at
HIV-1 LTR and consequently the acetylation of core histones
and recruitment of RNAP II.
In the complementary experiments using either HeLa
(Supplementary Figure S8) or Jurkat T cells (Supplementary
Figures S7 and S9), we show that overexpression of CBF-1 led
to a decline in RNAP II levels and a concomitant rise of CIR,
mSIN3A and HDAC-1 levels at the promoter and the Nuc-1
region. In association with the HDAC-1 recruitment there was
also a decline in acetylated histone H3 and H4 levels at the
HIV LTR.
T-cell activation downregulates CBF-1 mRNA
expression
An important property of any putative repressor used to
establish HIV latency is that it must be removed following
T-cell activation. To examine whether CBF-1 expression is
altered during T-cell activation, we analyzed the cellular
levels of CBF-1 mRNA following activation of Jurkat cells
carrying a latent pHR0-luciferase provirus with antibodies to
the CD3 T-cell receptor and CD28 co-receptors. As shown
in Figure 7A, CBF-1 mRNA levels drop sharply (t1/2¼
15–30min) and remain at low levels for at least up to 3h of
treatment. In contrast, HIV-1 transcript levels rise rapidly
during the ﬁrst 60min of treatment, decline after NF-kB exit
from the nucleus and then rise again after 3h (Figure 7B).
The rapid decline in CBF-1 mRNA levels in response to T-cell
receptor stimulation places it in a small subset of transcrip-
tion factors that are downregulated during T-cell activation
(Argyropoulos et al, 2004). The most typical mRNA expres-
sion proﬁle in activated T cells is illustrated by b-actin
(Figure 7B), which shows relatively small changes in
mRNA levels for the ﬁrst 2h and then begins to rise as the
T cells become enlarged and more motile by 3h. The YY1
gene shows a ﬂat expression proﬁle throughout the activation
period (Figure 7A). Comparable results were obtained when
cells were activated by TNF-a, or PMA/PHA treatment
(Supplementary Figure S10). Consistent with the mRNA
results, following T-cell activation, CBF-1 protein levels de-
cline with t1/2¼3–5h (Figure 7C).
We conclude that in quiescent or unstimulated Tcells, where
CBF-1 levels are high and NF-kBl e v e l sa r el o w ,C B F - 1i sa b l et o
bind to the HIV LTR and recruits HDACs containing corepressor
complexes. This helps to establish repressive chromatin struc-
tures at LTR, which accelerate entry into latency. Following
induction of NF-kB, nuclear levels of NF-kB rise, CBF-1 and its
recruited corepressor complexes are replaced by NF-kB and its
coactivators, and HIV transcription resumes.
Discussion
Silencing of HIV by CBF-1
In this paper, we have demonstrated that CBF-1 is a speciﬁc
and highly potent inhibitor of HIV-1 transcription. CBF-1
is recruited to the HIV LTR by binding primarily to the two
NF-kB elements present in the enhancer region of HIV-1 LTR.
An additional CBF-1-binding site is located at position þ148
to þ153 downstream of the transcription start site, adjacent
to Nuc-1. Promoters that lack CBF-1-binding sites, such as the
CMV immediate-early promoter, are not repressed by CBF-1.
Direct evidence that endogenous levels of CBF-1 found in
T-cell lines help to restrict HIV transcription in latently
infected cells comes from experiments where intracellular
CBF-1 levels were knocked down using lentiviral vectors
expressing shRNA. For example, in Figure 6 we showed
that when latent proviruses were induced by ablation of
CBF-1 or activation by TNF-a, there is a decline in CBF-1,
CIR and HDAC-1 levels and a parallel increase in RNAP II
and acetylated histones at the HIV LTR. Thus, knockdown of
CBF-1 partially relieves the chromatin blocks and results
in signiﬁcant activation of latent proviruses. However, max-
imal induction of the HIV LTR also requires the expression of
NF-kB, indicating that additional restrictions on HIV tran-
scription are present. In the complementary series of experi-
Figure 6 Knockdown of CBF-1 by shRNA leads to enhanced his-
tone acetylation. The distribution of transcription factors on the HIV
LTR in HIV mCherry clone 2 cells superinfected with lentiviral
vectors carrying shRNA was analyzed by quantitative chromatin
immunoprecipitation (ChIP) assays using the indicated antibodies
before and after TNF-a stimulation. Black bars: empty vector
(minus shRNA); red bars: CBF-1 shRNA; purple bars: cells treated
with 20ng/ml TNF-a for 24h.
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that overexpression of CBF-1 decreases HIV gene expression
in newly infected cells and enhances the recruitment of
HDAC-1 to the promoter.
The recruitment of HDACs to the LTR seems to be the
major mechanism by which CBF-1 blocks transcription. This
is similar to the mechanisms that have been proposed pre-
viously for the blocking of HIV-1 transcription by YY1 and
p50 (He and Margolis, 2002; Williams et al, 2006). In contrast
to the report of Williams et al (2006), we have been unable to
demonstrate that p50 acts as a repressor of HIV proviruses in
the many different cell lines that we have examined. In our
hands, p50 strongly activates transcription in HIV proviruses
in HeLa cells and weakly activates HIV transcription in Jurkat
T cells (Figure 1). We were also unable to demonstrate
activation of latent HIV proviruses with shRNA to p50
under conditions where partial activation of the provirus
could be observed using shRNA to CBF-1. It is possible that
association of p50 with the HIV LTR is a speciﬁc property of
the J-Lat 6.3 cell line that they employed in their studies. In
contrast to p50, we have easily detected YY1 at the HIV LTR
in latently infected T-cell lines. YY1 is known to inhibit HIV
replication when overexpressed in trans (Coull et al, 2000).
However, the presence of YY1 does not strictly correlate with
the recruitment of HDACs in T cells. Following proviral
induction by NF-kB, YY1 levels actually rise slightly. This is
possibly due to the dual capacity of YY1 to act as a repressor
and activator of transcription.
CBF-1 cofactor utilization
To mediate the repression of Notch-responsive genes, CBF-1
recruits different HDAC corepressor complexes through its
repression domain. These include either SMRT/Sin3 (Hsieh
and Hayward, 1995; Hsieh et al, 1996; Kao et al, 1998) or
CIR/N-CoR/SMRT/SKIP (Hsieh et al, 1999). Both complexes
contain HDACs that are able to deacetylate nearby histones.
Alternatively, in certain cases, CBF-1 can restrict transcription
by competitively inhibiting the interaction of TFIIA and TFIID
at the promoter (Olave et al, 1998).
To determine the speciﬁc mechanisms used by CBF-1 to
repress HIV transcription, and to deﬁne the composition of
the corepressor complexes, we performed extensive ChIP
analyses in several latently infected cell lines. Binding of
CBF-1 to the HIV LTR led to the recruitment of CIR, Sin3a,
HDAC-1 and a small amount of HDAC-2. The recruitment of
the HDACs resulted in a dramatic loss of acetylated core
histones at the HIV LTR when CBF-1 was present.
Indirect effects of CBF-1 could also have a negative impact
on HIV transcription since many other NF-kB-regulated genes
are also inhibited by CBF-1. For example, CBF-1 interacts
with a dual NF-kB/CBF-1-binding site in both the IkBa
promoter and the NF-kB2 promoter and inhibits their activity
(Oswald et al, 1998; Oakley et al, 2003). Similarly, IL-6, a
cytokine which is involved in T-cell activation, proliferation
and survival is downregulated by CBF-1 (Liu et al, 2005).
Regulation of CBF-1 levels during T-cell activation
A unique feature of CBF-1 that makes it a particularly
attractive candidate as a factor controlling HIV latency is
that it is among the rare subset of genes that are down-
regulated during T-cell activation. Unactivated T cells (or
primary T cells) show higher levels of CBF-1 mRNA and
protein, but CBF-1 levels fall rapidly in response to prolif-
erative stimulation. In contrast, under these conditions the
Figure 7 CBF-1 mRNA and protein are rapidly downregulated in activated T cells. Jurkat cells were activated by treatment with anti-CD3
and anti-CD28 antibodies and the levels of mRNA were accessed by quantitative real-time PCR. (A) CBF-1 mRNA (red) and YY1 (light blue).
(B) HIV mRNA (yellow) and b-actin mRNA (dark blue). (C) CBF-1 and Spt5 protein levels were measured by western blotting at various times
following T-cell activation.
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Margolis, 2002; Williams et al, 2006).
Role of CBF-1 in promoting HIV latency
The rarity of latently infected T cells in HIV-infected patients
precludes direct analyses of the proteins present at the
provirus. The biochemical analyses in this paper were there-
fore conducted using a series of clones carrying transcrip-
tionally silent proviruses derived from lentiviral vectors
carrying marker proteins. An important feature of the clones
we have studied is that essentially the entire population can
be reactivated following induction of NF-kB. Although Jurkat
Tcells are a transformed cell line, we believe that the under-
lying molecular mechanisms that lead to latency in Jurkat
Tcells are likely to be similar to those seen in HIV-1-infected
patients since in both cases transcriptional reactivation of the
latent proviruses requires induction of NF-kB (Brooks et al,
2003; Arlen et al, 2006) and inhibitors of HDACs are able to
partially reactivate latent proviruses in cells isolated from
patients as well as in transformed cell lines (Ylisastigui et al,
2004; Klichko et al, 2006).
Numerous studies have demonstrated that formation of a
restrictive chromatin environment is a prerequisite for the
entry of HIV into latency. Although it was originally believed
that latency arises when HIV integrates into pre-existing
regions of heterochromatin (Jordan et al, 2003), recent
high-throughput sequencing studies of HIV integration sites
of infected resting CD4þ Tcells in HIV-infected patients with
effective suppression of viremia have shown that HIV pre-
ferentially integrates into regions containing actively tran-
scribed genes and is almost never found in heterochromatic
regions (Han et al, 2004; Lewinski et al, 2005). Similarly, the
latently infected Jurkat cells we have studied all carry
integrants into actively transcribed genes (data not shown).
It therefore seems likely that epigenetic shutdown mechan-
isms leading to HIV silencing are responsible for the induc-
tion of HIV latency.
Consistent with this idea, our ChIP experiments have
shown that CBF-1 functions by recruiting corepressor com-
plexes containing HDACs to induce transcriptional silencing.
As shown in Figure 8, in quiescent or unstimulated T cells,
where CBF-1 levels are high, the HIV LTR is repressed. After
binding to the speciﬁc sequences at HIV-1 LTR, CBF-1 recruits
HDAC-containing corepressor complexes. We have been able
to conﬁrm the results of du Che ´ne ´ et al (2007) and Marban
et al (2007) that latent HIV proviruses also carry proteins that
are typically associated with heterochromatin, including
methylated histones and HP1a and HP1g (data not shown).
It therefore seems likely that establishment of restrictive
heterochromatic structures on the latent HIV provirus in-
volves a series of sequential events starting with the recruit-
ment of HDACs to the promoter via CBF-1, followed by
methylation of histones by Suv39H1 and binding of the HP
proteins to the methylated histones.
An inevitable consequence of HIV silencing is the blocking
of Tat production. As Tat levels become restricted, RNAP II
elongation becomes increasingly inefﬁcient and the virus is
able to enter latency. Following induction of T cells carrying
latent proviruses, NF-kB p65 is able to displace CBF-1 and its
associated corepressor complexes from the HIV LTR. NF-kB
p65 is then able to recruit transactivators such as the histone
acetyl transferase (HAT) p300. Acetylation of core histones by
HATs then leads to the recruitment of the SWI/SNF chromatin
remodeling machinery and restores access of transcription
machinery to the promoter, leading to the initial Tat- and Rev-
independent rounds of HIV transcription. Once Tat and Rev
are synthesized, a positive feedback mechanism is estab-
lished, and the virus becomes committed to the syntheses
of full length transcripts and productive growth.
Materials and methods
Lentiviral constructs
The lentiviral vectors pHR0 and pHR0SIN-18, a SIN vector (Dull et al,
1998) were modiﬁed by insertion of a polylinker (BamH1, SmaI,
SalI, MscI, SpeI, SacII and XhoI) between the BamH1 and XhoI sites
to create pHR0P and pHR0P-SIN-18. The PCR-ampliﬁed luciferase
gene from pGL3 basic vector (Invitrogen) was inserted into pHR0P
to generate pHR0P-Luc. In pHR0P-SIN-18-Luc, expression of the
luciferase gene is under the control of the internal human CMV
immediate-early promoter. pHR0P-SIN-Flag-CBF-1-IRES-Neo carries
the Flag-CBF-1 insert cloned between the BamH1 and SalI sites of
pHR0P-SIN-18 and an IRES and Neomycin gene cloned between the
SalI and XhoI sites of the polylinker. pHR0-P-PNL-mCherry was
produced by cloning the NotIt oXhoI fragment from HIV-1 pNL4-3
into the pHR0P vector. The shRNA vector pHR0P-SIN-CMV-GFP was
generated by cloning the CMV-GFP insert into the SacII to XhoI sites
of the pHR0P-SIN-18 vector. shRNA inserts were initially cloned into
the pSuper vector (Oligoengine). The shRNA plus the H1 promoter
were then cloned into pHR0P-SIN-CMV-GFP between the BamH1
and SalI sites.
Generation of VSV-G-pseudotyped viral particles
293T and HeLa cells were grown in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum. T-cell lines
CEM and Jurkat were maintained in RPMI 1640 medium
supplemented with 10% FCS.
Pseudotyped HIV-based lentiviral vector particles pseudotyped
with the vesicular stomatitis virus glycoprotein (VSV-G) were
produced using a three-plasmid co-transfection procedure (Naldini
et al, 1996). The viruses were concentrated by ultracentrifugation,
aliquoted and frozen at  801C until use.
Figure 8 Model for regulation of HIV latency by CBF-1. In latently
infected cells, transcription is blocked by a repressive chromatin
structure induced by CBF-1 binding to the HIV LTR. CBF-1 directly
recruits histone deacetylases to the promoter, which repress tran-
scription. Subsequently, histone methylases and HP1 proteins es-
tablish heterochromatic structures on the HIV LTR. Activation of
HIV by stimulation of NF-kB leads to displacement of CBF-1 from
the LTR and recruitment of histone acetyltransferases and chroma-
tin-remodeling factors that lead to the formation of an active
transcription unit.
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ChIP was done as previously described (Kim et al, 2006). To activate
cells, we used either 10ng/ml TNF-a or 25ml per 10
6 cells CD3/
CD28 antibodies bound Dynal beads (Dynal Biotech). Most
antibodies were purchased from Santa Cruz, including anti-RNAP
II (N-20), CBF-1(H-50), CIR (C-19), mSIN3A (AK-11), HDAC-1
(H-51), HDAC-2 (H-54) and p65 (C-20). Anti-acetylated histone-3
and -4 antibodies were obtained from Upstate. Each sample (5%)
was analyzed by quantitative real-time PCR to access the amount
of sample immunoprecipitated by individual antibody. A non-
antibody control value was subtracted from each sample value to
remove the background counts.
Western blot
Western blotting was performed according to standard protocols.
Anti-CBF-1 (Chemicon or Santa Cruz), anti-Flag (Sigma) and
secondary HRPO-conjugated anti-rabbit or anti-mouse antibodies
were (Dako) were used.
Electromobility shift assay
GST fusion CBF-1 protein produced in Escherichia coli was kindly
provided by Katherine Jones. The gel shift probes were prepared by
cleaving the HIV-1 LTR with either HindIII to BssHII (CBF-1 region:
þ76 to þ255) or AvaIt oPvuII (NF-kB region:  160 to  22). As a
negative control, we employed the NarIt oMscI fragment of the
pcDNA3 vector (Invitrogen). The fragments were labeled with g-
32P
ATP and T4 polynucleotide kinase. Binding reactions contained the
32P-labeled DNA fragment (10000c.p.m.) and either GST-CBF-1 or
GSTalone as a control. Reactions were performed in electromobility
shift assay buffer (20mM HEPES at pH 7.9, 0.2mM EDTA, 20%
glycerol, 100mM KCl, 1mM dithiothreitol), containing 2mg poly
(dI-dC), 1mg bovine serum albumin (BSA), 10mM ZnCl2, 0.5mM
phenylmethylsulfonyl ﬂuoride and 100ng/ml each of leupeptin and
aprotinin for 15min at room temperature. Reaction mixtures were
fractionated on 5% non-denaturing polyacrylamide gels (acryla-
mide/bis-acrylamide, 37.5:1) containing 2.5% glycerol and TGE
buffer (25mM Tris, 192mM glycine and 1mM EDTA).
Quantitation of transcripts by real-time PCR
Total RNA was isolated from 2 10
6 cells using Trizol reagent
(Gibco-BRL) according the manufacturer’s instructions. Equal
amounts of RNA (1–2mg) were employed in cDNA synthesis using
M-MLV reverse transcriptase (Invitrogen) for 1h at 371C in a total
volume of 25ml containing RT buffer, DTT, 80U of RNasin (40U/ml;
Promega) and 1ml of either oligo-dT or random hexamer primer.
Puriﬁed cDNA (10%) was used as a template in real-time PCR
reactions using a DNA engine Opticon-2 (MJ) Real-T-PCR machine.
Data analysis utilized the Sequence Detector software (version 1.6.3
and 1.7) to determine threshold cycle, Ct, and reduced normalized
ﬂuorescence values, DRn, for each ampliﬁed product for each time
point.
Luciferase assays
Cells transfected in six-well plates were harvested after 48h,
washed twice in phosphate-buffered saline, and then lysed in 100–
200mlo f1   Passive Lysis Buffer (Promega) for 30min at room
temperature. From each lysate, 5ml was assayed with 50mlo f
enzyme substrate provided with Luciferase Assay System kit
(Promega) using microplate luminometer with an injection unit
(Bio-Rad).
Flow cytometry
Cells were subjected to ﬂow cytometric analysis using FACScan ﬂow
cytometer (Becton Dickinson, Franklin Lakes, NJ) and data were
analyzed with WinMDI software.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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